‘Adjuvant’ —forsooth! Now we know from the list of contents headings of your December issue that you really believe you edit the ‘British Journal of Pharmaco-psychiatry‘! We, the ‘adjuvant therapists', may be a motley crew of neurosurgeons, behaviour therapists, analysts and occupational therapists, but with only our scalpels, training schedules, couches and raffia we should be able to rescue most of our patients from the machinations of you druggists! Adjuvants of the world arise—we have nothing to lose but our humanity!

The paper by Sved et al. (1) serves as a further reminder of the need for the monitoring of drugs used in psychiatry. We would however urge great caution in accepting the conclusions which the authors draw regarding resistance to chlorpromazine therapy. We fear a turn sequitur.

The correspondence in the Journal on the topic of the N.A.M.H. ‘Guidelines' makes me wonder whether the Joint Working Party would not perform its task in the most satisfactory way if it would supervise the making of a cartoon film showing how violent patients should be managed.